Login / Signup

Differences in Management Between Dermatologists and Oncologists for Acneiform Eruptions in Patients on Monoclonal Antibody Epidermal Growth Factor Receptor Inhibitors.

Sarah OlielRachel BierbrierKathleen D'AguannoKhashayar EsfahaniKevin Pehr
Published in: Journal of cutaneous medicine and surgery (2023)
Keyphrases
  • epidermal growth factor receptor
  • monoclonal antibody
  • end stage renal disease
  • tyrosine kinase
  • ejection fraction
  • newly diagnosed
  • advanced non small cell lung cancer
  • chronic kidney disease
  • prognostic factors